Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Ferial Haffajee among graduates at Summer Graduation

2016-12-02

A total of 124 master’s, 37 doctoral degrees, and
464 undergraduate degrees are conferred on students from
all seven faculties during the Summer Graduations.
Photo: Johan Roux

Graduation is a time to celebrate and to reap the fruits of hard work. The journalist Ferial Haffajee (Humanities) will be among the 124 master’s and 37 doctoral students receiving their qualifications in all seven faculties at the Summer Graduation of the University of the Free State (UFS). At the ceremonies on 8 December 2016 in the Callie Human Centre on the Bloemfontein Campus, the university will also confer 264 Education qualifications to students from its South Campus, as well as 200 undergraduate degrees in the Faculty of Health Sciences.

Haffajee joins likes of Tutu and others

Haffajee, a renowned newspaper editor whose expertise has made her one of the most prominent journalists in South Africa, will receive an honorary doctorate at the morning ceremony. Until recently she was the editor-in-chief of City Press newspaper. She joins the likes of Desmond Tutu, and others who have received honorary doctorates at the UFS.

Earlier this year, four distinguished individuals also received honorary doctorates from the university. They were Max du Preez, Trevor Manuel, Prof Joel Samoff, and Dr Reuel Jethro Khoza. The Summer Graduation once again promises to deliver the cream of academic excellence.

Dr Rakometsi to address UFS graduates

The guest speaker at both ceremonies is Dr Mafu Rakometsi, Chief Executive Officer of Umalusi. Dr Rakometsi also serves on the board of the Council of Higher Education. He is deeply committed to see the South African education system function at an optimum level in order to give all children equal educational opportunities.

Master’s and Doctoral degrees: All faculties
Date: 8 December 2016
Place: Callie Human Centre, Bloemfontein Campus
Time: 09:00

Education qualifications – South Campus, as well as undergraduate degrees in the Faculty of Health Sciences
Date: 8 December 2016
Place: Callie Human Centre, Bloemfontein Campus
Time: 14:30

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept